Bicara Therapeutics
$20.39
0
+$0.5+2.49% Today
Statistics
Day High
21.05
Day Low
19.78
52W High
20.46
52W Low
8.71
Volume
194,567
Avg. Volume
523,877
Mkt Cap
1.12B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
19MayExpected
Expected EPS
-0.681333
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-100.56MNet Income
Analyst Ratings
$27.00Average Price Target
The highest estimate is 42.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy 50%
Hold 50%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow BCAX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts. Bicara Therapeutics Inc. is a subsidiary of Biocon Limited.
Show more...
CEO
Dr. Claire Mazumdar Clemon M.B.A., Ph.D.
Employees
55
Country
US
ISIN
US0554771032
Listings
0 Comments
Share your thoughts
FAQ
What is Bicara Therapeutics stock price today?▼
The current price of BCAX is $20.39 USD — it has increased by +2.49% in the past 24 hours. Watch Bicara Therapeutics stock price performance more closely on the chart.
What is Bicara Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bicara Therapeutics stocks are traded under the ticker BCAX.
Is Bicara Therapeutics stock price growing?▼
BCAX stock has risen by +9.37% compared to the previous week, the month change is a +21.75% rise, over the last year Bicara Therapeutics has showed a +61.37% increase.
What is Bicara Therapeutics market cap?▼
Today Bicara Therapeutics has the market capitalization of 1.12B
When is the next Bicara Therapeutics earnings date?▼
Bicara Therapeutics is going to release the next earnings report on May 19, 2026.
What were Bicara Therapeutics earnings last quarter?▼
BCAX earnings for the last quarter are -0.68 USD per share, whereas the estimation was -0.68 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bicara Therapeutics revenue for the last year?▼
Bicara Therapeutics revenue for the last year amounts to 0 USD.
What is Bicara Therapeutics net income for the last year?▼
BCAX net income for the last year is -100.56M USD.
How many employees does Bicara Therapeutics have?▼
As of April 01, 2026, the company has 55 employees.
In which sector is Bicara Therapeutics located?▼
Bicara Therapeutics operates in the Health Care sector.
When did Bicara Therapeutics complete a stock split?▼
Bicara Therapeutics has not had any recent stock splits.
Where is Bicara Therapeutics headquartered?▼
Bicara Therapeutics is headquartered in Boston, US.